These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 27807213)

  • 21. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
    Choudhry S; Bagga A; Hari P; Sharma S; Kalaivani M; Dinda A
    Am J Kidney Dis; 2009 May; 53(5):760-9. PubMed ID: 19268410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A case of high-age minimal change nephrotic syndrome relapse after 18-year remission and effective treatment with steroid and cyclosporin combined therapy].
    Yoshimoto K; Wada T; Iwata Y; Sakai N; Shimizu M; Furuichi K; Yokoyama H; Kobayashi K
    Nihon Jinzo Gakkai Shi; 2000 Oct; 42(8):640-3. PubMed ID: 11195400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of membranous lupus nephritis.
    Moroni G; Maccario M; Banfi G; Quaglini S; Ponticelli C
    Am J Kidney Dis; 1998 Apr; 31(4):681-6. PubMed ID: 9531186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tacrolimus as the first-line agent in adult-onset minimal change disease: A randomized controlled study.
    Patil MR; Divyaveer SS; Raychaudhary A; Trivedi M; Mahajan C; Sarkar D; Pandey R
    Saudi J Kidney Dis Transpl; 2019; 30(1):129-137. PubMed ID: 30804274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short term efficacy of intravenous dexamethasone and methylprednisolone therapy in steroid resistant nephrotic syndrome.
    Hari P; Bagga A; Mantan M
    Indian Pediatr; 2004 Oct; 41(10):993-1000. PubMed ID: 15523124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tacrolimus as rescue therapy for adult-onset refractory minimal change nephrotic syndrome with reversible acute renal failure.
    Li X; Xu N; Li H; Han F; Wang R; He Q; He X; Chen J
    Nephrol Dial Transplant; 2013 Sep; 28(9):2306-12. PubMed ID: 23787554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment with tacrolimus and prednisolone is preferable to intravenous cyclophosphamide as the initial therapy for children with steroid-resistant nephrotic syndrome.
    Gulati A; Sinha A; Gupta A; Kanitkar M; Sreenivas V; Sharma J; Mantan M; Agarwal I; Dinda AK; Hari P; Bagga A
    Kidney Int; 2012 Nov; 82(10):1130-5. PubMed ID: 22763815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multitarget therapy for induction treatment of lupus nephritis: a randomized trial.
    Liu Z; Zhang H; Liu Z; Xing C; Fu P; Ni Z; Chen J; Lin H; Liu F; He Y; He Y; Miao L; Chen N; Li Y; Gu Y; Shi W; Hu W; Liu Z; Bao H; Zeng C; Zhou M
    Ann Intern Med; 2015 Jan; 162(1):18-26. PubMed ID: 25383558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of cyclosporine combination therapy for new-onset minimal change nephrotic syndrome in adults.
    Fujiwara A; Hirawa N; Kobayashi Y; Yatsu K; Katsumata M; Ehara Y; Okuyama Y; Yutoh J; Kaneda T; Fujita M; Yamamoto Y; Saka S; Toya Y; Yasuda G; Umemura S
    Clin Exp Nephrol; 2015 Apr; 19(2):240-6. PubMed ID: 24771147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methylprednisolone treatment in children with nephrotic primary focal segmental glomerulosclerosis.
    Opastirakul S; Chartapisak W
    J Med Assoc Thai; 2006 Dec; 89(12):2145-9. PubMed ID: 17214070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amelioration of the adverse effects of prednisolone by rituximab treatment in adults with steroid-dependent minimal-change nephrotic syndrome.
    Miyabe Y; Takei T; Iwabuchi Y; Moriyama T; Nitta K
    Clin Exp Nephrol; 2016 Feb; 20(1):103-10. PubMed ID: 26138356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autoimmune thyroiditis and vitiligo in a child with minimal change nephrotic syndrome.
    Kuzmanovska DB; Shahpazova EM; Kocova MJ; Gruevska SJ; Petrushevska G
    Pediatr Nephrol; 2001 Dec; 16(12):1137-8. PubMed ID: 11793116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rituximab for minimal change disease in adults: long-term follow-up.
    Bruchfeld A; Benedek S; Hilderman M; Medin C; Snaedal-Jonsdottir S; Korkeila M
    Nephrol Dial Transplant; 2014 Apr; 29(4):851-6. PubMed ID: 24121763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Steroid responsiveness and frequency of relapse in adult-onset minimal change nephrotic syndrome.
    Nakayama M; Katafuchi R; Yanase T; Ikeda K; Tanaka H; Fujimi S
    Am J Kidney Dis; 2002 Mar; 39(3):503-12. PubMed ID: 11877569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of methylprednisolone pulse therapy in steroid-resistant nephrotic syndrome.
    Mori K; Honda M; Ikeda M
    Pediatr Nephrol; 2004 Nov; 19(11):1232-6. PubMed ID: 15322892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Clinical Course of Minimal Change Nephrotic Syndrome With Onset in Adulthood or Late Adolescence: A Case Series.
    Maas RJ; Deegens JK; Beukhof JR; Reichert LJ; Ten Dam MA; Beutler JJ; van den Wall Bake AWL; Rensma PL; Konings CJ; Geerse DA; Feith GW; Van Kuijk WH; Wetzels JF
    Am J Kidney Dis; 2017 May; 69(5):637-646. PubMed ID: 28089478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The efficacy of cyclosporine A in adult nephrotic syndrome with minimal change disease and focal-segmental glomerulosclerosis: a multicenter study in Korea.
    Lee HY; Kim HS; Kang CM; Kim SG; Kim MJ
    Clin Nephrol; 1995 Jun; 43(6):375-81. PubMed ID: 7554521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term outcome of biopsy-proven minimal change nephropathy in Chinese adults.
    Szeto CC; Lai FM; Chow KM; Kwan BC; Kwong VW; Leung CB; Li PK
    Am J Kidney Dis; 2015 May; 65(5):710-8. PubMed ID: 25465164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of pemphigus vulgaris with brief, high-dose intravenous glucocorticoids.
    Werth VP
    Arch Dermatol; 1996 Dec; 132(12):1435-9. PubMed ID: 8961871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tacrolimus therapy in pediatric patients with treatment-resistant nephrotic syndrome.
    Loeffler K; Gowrishankar M; Yiu V
    Pediatr Nephrol; 2004 Mar; 19(3):281-7. PubMed ID: 14758528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.